Virginia HB917 regulates the use of bulk drug substances in compounding pharmacies, requiring specific recordkeeping and compliance with FDA.
Virginia HB917 establishes regulations for compounding pharmacies, focusing on the use of bulk drug substances. It mandates that pharmacists obtain proof of FDA registration and inspection for the establishments manufacturing these substances. The bill requires pharmacists to maintain detailed records for compounded products, including the name and strength of the medication, the facility's control number, beyond-use date, pharmacy name and address, and quantity.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.